See All Slides - tctmd.com

Slides

Presentation TCT 2013

How Important Is Paravalvular Leak After TAVR and Will This Limit Its Penetration?

Presenter: Samir Kapadia

October 29, 2013

Presentation TCT 2013

TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial

Presenter: Petr Neuzil

October 29, 2013

Presentation TCT 2013

TCT-87. Targeting systolic anterior motion and left ventricular outflow tract obstruction in hypertrophic obstructed cardiomyopathy with a MitraClip

Presenter: Ulrich Schaefer

October 29, 2013

Presentation TCT 2013

Case Presentation 2: Patient with NSTEMI, Cardiogenic Shock, Occluded RCA and Severe Left Main Disease

Presenter: Jacek Legutko

October 29, 2013

Presentation TCT 2013

Synthesis of the Current US and EU Guidelines for Management of SIHD (Similarities and Differences)

Presenter: Kevin Beatt

October 29, 2013

Presentation TCT 2013

TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

Presenter: Elvin Kedhi

October 29, 2013

Presentation TCT 2013

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

Presenter: Felix Mahfoud

October 29, 2013

Presentation TCT 2013

TCT-5. Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study

Presenter: Thomas Stuckey

October 29, 2013

Presentation TCT 2013

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Presenter: Gerhard Schymik

October 29, 2013

Presentation TCT 2013

Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices

Presenter: Koen Keirse

October 29, 2013

Advertisement

Slides

How Important Is Paravalvular Leak After TAVR and Will This Limit Its Penetration?

TCT-61. Optimized External Focused Ultrasound for Renal Sympathetic Denervation – Wave II trial

TCT-87. Targeting systolic anterior motion and left ventricular outflow tract obstruction in hypertrophic obstructed cardiomyopathy with a MitraClip

Case Presentation 2: Patient with NSTEMI, Cardiogenic Shock, Occluded RCA and Severe Left Main Disease

Synthesis of the Current US and EU Guidelines for Management of SIHD (Similarities and Differences)

TCT-19. The Impact of Coronary Lesion Severity on Drug-eluting Stent Outcomes in Patients with and without Diabetes Mellitus

TCT-60. Clinical and Procedural Outcomes of Renal Artery Denervation In Real World Patients with Hypertension: An Update From the Global SYMPLICITY Registry

TCT-5. Relationship Between High Platelet Reactivity on Clopidogrel and Outcomes After DES Implantation: Two-Year Results From the ADAPT-DES Study

TAVI Karlsruhe (TAVIK) – a comparison of minimal invasive and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis and intermediate risk for conventional surgery

Use Of 4 French Systems For Treating Fem-Pop Lesions: Advantages And Disadvantages: Lessons From The 4EVER Trial Using Astron Pulsar Stents And No Closure Devices

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content